← Eichor
Study identifier: NCT07065799 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Respiratory Strategies in COPD Patients With Persistent Hypercapnia Following Exacerbation

Condition: COPD · Hypercapnia · Exacerbation Copd  ·  Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

PhaseNA
Planned participants31
Who can joinAll sexes, 18 Years to 90 Years
Healthy volunteersNo

About this study

This multicenter, cross-over study aims to investigate the effects of two different respiratory strategies, the use of high flow nasal cannula (NHF) and the use of home mechanic ventilation (HMV), both associated with standard oxygen therapy, in patients with COPD and persistent hypercapnia following a severe acute exacerbation. The purpose is to evaluate whether the clinical benefits, in terms of reduction in PaCO2 levels, resulting from the use of NHF are non-inferior to those obtained from the use of HMV. Partecipants will be randomized at 1:1 ratio into two groups: group 1: will start the respiratory strategy under study (NHF + standard oxygen therapy) as first treatment group 2 will start the control respiratory strategy (HMV + standard oxygen therapy) as first treatment. The study has a crossover design: each patient will undergo treatment with the two different respiratory strategies, NHF and HMV, each lasting for 3 months

This description comes directly from the study's public registry record.

Talk to the study team

Lara Pisani, Prof.ssa  ·  0512143257  ·  lara.pisani@unibo.it

Always discuss trial participation with your own doctor first.

Locations (5)

Ospedale S DonatoArezzo, ItalyRecruiting
Bolzano HospitalBolzano, ItalyRecruiting
Azienda Ospedaliera Universitaria Policlinico "G. Rodolico-Sn Marco"Catania, ItalyRecruiting
ICS Maugeri Spa Società Benefit IRCCSPavia, ItalyRecruiting
Azienda Unità Sanitaria LocalePiacenza, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07065799